Full-Time

Medical Science Liaison

Confirmed live in the last 24 hours

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Biotechnology
Healthcare

Compensation Overview

$132k - $165kAnnually

+ Bonus + Incentives + Restricted Stock Units

Senior

Houston, TX, USA + 4 more

More locations: Nashville, TN, USA | Dallas, TX, USA | Phoenix, AZ, USA | Atlanta, GA, USA

Remote role requiring at least 60% travel to key customers and support of field teams across multiple states.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Marketing
Requirements
  • Advanced scientific or clinical degree required- PhD, MD, NP, PA, CGC
  • At least 5 years of clinical experience – preferably urology/radiation oncology-focused
  • Prior experience as an MSL in the introduction of a novel clinical assay preferred
  • Advanced understanding of tumor biology and molecular testing and/or related working experience critical for success in this role
  • Outstanding interpersonal skills and a team player, demonstrating customer centricity, passion for patients and desire to help the cross-functional teams succeed
  • Outstanding oral and written presentation skills, to convey complex study findings and data to audiences with varying degrees of scientific/clinical/healthcare knowledge
  • Outstanding interpersonal skills in building rapport, probing, situational awareness and adapting communication and content based on real time needs of audience
  • Willingness and ability to travel within defined region with proximity to a major airport
  • A detail-oriented, organized, self-starter approach, with strong ability to multitask yet prioritize workload
Responsibilities
  • Provide clinical product education to our customers and our field teams with the goal of driving understanding and adoption of our novel diagnostics
  • Partner closely across the organization to serve as a scientific and clinical resource for the company's products and associated disease states
  • Provide both internal and external educational support
  • Support the development of multi-channel medical educational activities and tools across the product lifecycle such as speaker programs, educational materials, slide creation, and on-line educational events
  • Function as a field-based member of the marketing department within the commercial team
  • Devote approximately 70% of time to client-facing activities mostly at the request of the sales team, in-person and remote, and 30% spent on internal collaborations and special projects

Veracyte develops and commercializes genomic tests for early cancer detection and diagnosis. Their tests analyze genetic information from non-invasive samples like nasal swabs or tissue biopsies, providing insights into cancer presence and progression. This helps healthcare providers, such as hospitals and clinics, make informed treatment decisions. Veracyte stands out from competitors by focusing on non-invasive testing methods and continuously investing in research to expand their product offerings. Their goal is to improve cancer diagnosis accuracy, leading to better patient outcomes and more efficient healthcare.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

2008

Growth & Insights
Headcount

6 month growth

5%

1 year growth

7%

2 year growth

12%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increasing demand for personalized medicine boosts Veracyte's genomic diagnostics market.
  • AI integration enhances the accuracy and speed of Veracyte's cancer diagnostics.
  • Regulatory support is improving, accelerating Veracyte's market entry and adoption.

What critics are saying

  • Potential bias in genomic tests due to lack of diversity in development.
  • Upcoming MRD assay launch may face policy update challenges with payers.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection.
  • The Decipher Prostate genomic classifier aids in prostate cancer prognosis.
  • Veracyte's nasal swab test improves early lung cancer risk assessment.

Help us improve and share your feedback! Did you find this helpful?